Bavarian Nordic A/S (BVNKF)
OTCMKTS · Delayed Price · Currency is USD
36.36
+0.15 (0.40%)
Jul 31, 2025, 11:28 AM EDT
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.83 billion as of August 1, 2025. Its market cap has increased by 36.68% in one year.
Market Cap
2.83B
Enterprise Value
2.66B
Revenue
902.86M
Ranking
n/a
PE Ratio
14.81
Stock Price
$36.36
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.83B, an increase of 41,691.88%. That is a compound annual growth rate of 25.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.83B | 36.93% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | 1.80B | 116.49% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |